KalshiChiusoVerifica disponibilitàKYC richiesto2% di commissioneDati di risoluzione verificatiDiscretamente calibratoQuesto mercato è chiuso e in attesa di una risoluzione confermata.
In attesa di risoluzione verificata
CoinRithm attende un regolamento confermato dal provider prima di trattare questo mercato come risolto.
Probabilità implicita attuale
Before 2027 35%In testa tra 3 esiti
Qualità del mercato
35 / 100
Bassa qualitàVolume 24h
—
Liquidità
29,7K €
Alta liquiditàDati di mercato
Aggiornato 12 minuti fa
24 mar 26, 14:00 UTC1 set 26, 03:59 UTC
Trend
35%
20%
2%
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
FDA moves BPC-157 to Category 1 by which date?
PolymarketHantavirus pandemic in 2026?
PolymarketWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiWill we get AGI before 2027?
Manifold MarketsFDA approves skin cancer vaccine by which date?
PolymarketMeasles cases in 2026?
KalshiRegole
If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Sep 1, 2026, then the market resolves to Yes.
Si regola tramite:Food and Drug Administration
- The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility.
- Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion.
- If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Nov 1, 2026, then the market resolves to Yes.
- If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Jan 1, 2027, then the market resolves to Yes.
Mercati aperti
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No97%
- Yes3%
- Volume totale
- 15,6 Mln €
- Volume 24h
- 18K €
POLYMARKETNew pandemic in 2026?
- No94.1%
- Yes5.9%
- Volume totale
- 920,1K €
- Volume 24h
- 4K €
KALSHIMedtronic cardiovascular growth in Q2
- Above 8%92%
- Above 9%81%
- Above 11.5%53%
+6 altri esiti
- Volume totale
- 2,6K €
- Volume 24h
- 2,6K €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000+1.0pt98%
- Above 6000+2.0pt61%
+2 altri esiti
- Volume totale
- 868,1K €
- Volume 24h
POLYMARKETMeasles cases in U.S. in 2026?
- ↑3.5k100%
- ↑500+0.1pt100%
- ↑1k+0.1pt100%
+9 altri esiti
- Volume totale
KALSHIPandemic in 2026?
- No95%
- Yes5%
- Volume totale
- 612,7K €
- Volume 24h
- 1,2K €
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Which countries will report an Ebola disease case before October?
- What will RFK say during RNC Midterm Convention?
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will the FDA approve retatrutide?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- Measles cases in U.S. by September 30?
- Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?
- Will 3 mg THC beverages qualify as hemp under federal law?
Domande frequenti
- Quali sono le probabilità attuali per When will the FDA reclassify BPC-157 to Category 1??
- Kalshi quota Before 2027 al 35% al 10 settembre 2026.
- Quando si risolve When will the FDA reclassify BPC-157 to Category 1??
- When will the FDA reclassify BPC-157 to Category 1? dovrebbe risolversi il 1 settembre 2026.
- Come viene liquidato When will the FDA reclassify BPC-157 to Category 1??
- Kalshi liquida questo mercato come segue: If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Sep 1, 2026, then the market resolves to Yes.